• Image attribution tooltip
    Jeff J Mitchell via Getty Images

    HHS appeals block on vaccine mandate for healthcare workers

    State and federal lawmakers are battling over the fate of a federal COVID-19 vaccine mandate for health workers that will soon be decided in court. At least two major health systems have paused their requirements as a result.

    By Dec. 2, 2021
  • Image attribution tooltip

    Insurers now required to pay for at-home COVID-19 tests

    Nearly 150 million insured Americans will benefit from the move, helping to lower their costs for the over-the-counter tests that can retail for around $25 for one kit.

    By Dec. 2, 2021
  • Trendline

    Vertical integration and consolidation

    Healthcare companies merging with subsectors of the industry is a growing trend, although certainly not a new one.

    By Healthcare Dive staff
  • VA to resume Cerner medical record implementation early next year with new leadership

    Officials have released an updated deployment schedule for the beleaguered $16 billion EHR modernization project.

    By Dec. 2, 2021
  • Image attribution tooltip
    Courtesy of Merck & Co.

    FDA panel, after debate, narrowly backs Merck COVID pill

    While agency advisers raised concerns over molnupiravir's modest benefits and potential risks, a majority felt the antiviral drug is a needed option for COVID-19 patients at high risk of severe disease.

    By Jonathan Gardner • Updated Nov. 30, 2021
  • Image attribution tooltip
    Win McNamee via Getty Images

    Hospital lobby argues its case against 340B payment cut before SCOTUS

    Tuesday's arguments seemed to center around single words and phrases to determine whether HHS had the authority to change payment rules in 2018 for 340B hospitals, which serve a large share of low-income patients.

    By Dec. 1, 2021
  • Image attribution tooltip
    Stefani Reynolds / Stringer via Getty Images

    Hospital lobbying fails to stop looming Medicare cuts in year-end proposal

    Lawmakers on Thursday reached a bipartisan year-end spending bill that doesn't include provisions to push back or stop the upcoming Medicare cuts.

    By Updated Dec. 3, 2021
  • Image attribution tooltip
    Stefani Reynolds/Stringer via Getty Images

    Supreme Court to hear oral arguments in 340B case with billions of dollars at stake

    A lower court initially sided with the American Hospital Association, a decision that was later reversed by an appeals court, which AHA characterized as a "legal error."

    By Nov. 30, 2021
  • Image attribution tooltip
    Permission granted by BioNTech SE

    Healthcare worker vaccine mandate blocked nationwide in second ruling

    A federal judge granted a preliminary injunction Tuesday in a suit brought by 14 states challenging the requirement, following separate pauses in other states.

    By Updated Dec. 1, 2021
  • Image attribution tooltip
    Getty Images

    Biden admin investing $1.5B to quell healthcare staffing shortages, promote workforce equity

    The funding will go toward scholarship and loan repayment programs for healthcare students committing to work in hard-hit and high-risk communities, according to the White House.

    By Nov. 23, 2021
  • Image attribution tooltip
    Streeter Lecka via Getty Images

    Anesthesiologists say Blue Cross NC 'abusing' surprise billing ban to drive down rates

    Doctors are raising the alarm against what they perceive as Blue Cross NC's "take it or leave it" ultimatums to in-network clinicians, using the consumer protection legislation as a bargaining chip to negotiate more favorable rates.

    By Nov. 23, 2021
  • Image attribution tooltip
    Getty Images

    Ground ambulances, excluded from surprise billing ban, to get scrutiny from federal committee

    Recommendations from the new federal advisory committee will help inform policy changes to improve how charges and fees for ground ambulance services are disclosed to consumers, CMS said.

    By Nov. 22, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    FDA, aiming to curb another COVID-19 surge, clears Pfizer, Moderna boosters for all adults

    The decision comes as at least 10 states open up booster dose eligibility beyond the current, more limited authorizations while cases remain at high levels.

    By Ben Fidler • Nov. 19, 2021
  • Image attribution tooltip
    Alex Wong via Getty Images

    Biden admin proposes wide-reaching drug data collection in fourth surprise billing rule

    Payers and employers will need to give HHS an annual overview of the top 50 drugs across different areas, including the most frequently dispensed drugs and the most expensive prescription drugs.

    By Nov. 18, 2021
  • Image attribution tooltip
    Megan Quinn/Healthcare Dive

    MCIT breakthrough device payment pathway included in Cures 2.0 bill

    Lawmakers on Tuesday introduced a revised MCIT proposal in the next version of the 21st Century Cures Act, following last week's repeal of the final rule by CMS. Industry groups AdvaMed and MDMA backed the legislation.

    By Nick Paul Taylor • Nov. 18, 2021
  • Image attribution tooltip
    Joe Raedle via Getty Images

    30% of hospital healthcare workers remained unvaccinated as of September

    Healthcare workers in children's hospitals had the highest vaccination rates, along with those working in metropolitan counties, according to the analysis of Centers for Disease Control and Prevention data.

    By Nov. 18, 2021
  • Image attribution tooltip
    Jeenah Moon via Getty Images

    Pfizer asks FDA to authorize COVID-19 pill

    Study results released earlier this month showed the pill, when given soon after symptoms start, dramatically reduced the risk of COVID-19 hospitalization or death.

    By Ned Pagliarulo • Nov. 17, 2021
  • Congress, alongside provider and consumer groups, continues spat over surprise billing ban rules

    While payers and providers must start complying with the No Surprises Act by Jan. 1, the fight over rules implementing the ban is heating up as provider groups object to what they think is a favoring of insurers.

    By Nov. 17, 2021
  • CMS guides hospitals on co-location of staff, services

    The agency's final guidance on the practice of sharing resources in an effort to improve provider efficiency drew praise from the American Hospital Association.

    By Susan Kelly • Nov. 17, 2021
  • Image attribution tooltip
    Win McNamee via Getty Images

    As Congress weighs drug price restraints, ICER calls out 'unsupported' increases

    In a new report, ICER highlighted AbbVie's price hikes on Humira, which the group said resulted in more than $1 billion in U.S. spending last year without any new evidence of health benefits.

    By Jonathan Gardner • Nov. 16, 2021
  • Opinion

    Congress: Target the middlemen who drive up drug costs

    "The PBM market lacks the three elements essential for competition — choice, transparency and a lack of conflict of interest," antitrust attorney and former FTC policy director David Balto argues.

    By David Balto • Nov. 15, 2021
  • Image attribution tooltip
    Getty Images

    Biogen's pricey Alzheimer's drug contributes to major Medicare premium hikes

    The 15% jump in Part B premiums for 2022 is a case study in how just one expensive medication can affect the spending of millions in the U.S.

    By Nov. 15, 2021
  • Image attribution tooltip

    Permission for use provided by Zelis

    Sponsored by Zelis

    Zelis helps address new NSA and TiC regulations

    Learn more about innovative solutions that can help you comply with new regulations.

    Nov. 15, 2021
  • Image attribution tooltip
    Maddie Meyer via Getty Images

    Moderna, escalating dispute with NIH, claims government had no role in key vaccine patent

    The biotech claimed its NIH partners were involved only after a key discovery was made "by Moderna scientists using Moderna technology." The dispute over who invented a critical part of the vaccine could end up in court.

    By Jonathan Gardner , Ben Fidler • Nov. 12, 2021
  • Image attribution tooltip
    Win McNamee via Getty Images

    Biden nominates Robert Califf to return to as head of FDA

    If confirmed by Congress, the cardiologist would return to lead an agency taxed by a heavy workload reviewing COVID-19 drugs and vaccines.

    By Ned Pagliarulo , Jonathan Gardner • Updated Nov. 12, 2021
  • Image attribution tooltip
    Mario Tama via Getty Images

    Pfizer again asks FDA to authorize COVID-19 boosters for all adults

    Agency advisers had opposed a broad booster dose clearance in September, leading the FDA to limit use to older adults and those at high risk of COVID-19.

    By Jonathan Gardner • Nov. 10, 2021